Ryman Healthcare Limited
RHCGF
$1.44
$0.22518.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -143.96% | -879.29% | -203.76% | -184.11% | -163.30% |
| Total Depreciation and Amortization | 7.69% | 28.72% | 57.17% | 44.55% | 31.84% |
| Total Amortization of Deferred Charges | -13.99% | -11.88% | -10.87% | -10.87% | -10.87% |
| Total Other Non-Cash Items | 871.14% | 203.90% | 121.34% | 113.81% | 106.30% |
| Change in Net Operating Assets | -18.81% | -10.97% | -3.75% | -0.64% | 2.79% |
| Cash from Operations | -32.32% | -29.04% | -26.33% | -18.40% | -9.14% |
| Capital Expenditure | 40.71% | 39.56% | 38.52% | 39.39% | 40.27% |
| Sale of Property, Plant, and Equipment | -53.37% | -16.54% | 12.44% | -5.54% | -23.32% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.18% | 33.12% | 34.83% | 25.86% | 16.64% |
| Cash from Investing | 33.92% | 35.68% | 37.10% | 31.47% | 26.21% |
| Total Debt Issued | -100.00% | -84.56% | -71.72% | -60.27% | -53.93% |
| Total Debt Repaid | -26,210.19% | -17.62% | 99.52% | 99.54% | 99.55% |
| Issuance of Common Stock | -- | -- | -- | 9.23% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 275,712.78% | 26.20% | -100.00% | -100.02% | -100.05% |
| Cash from Financing | -55.41% | -65.59% | -73.63% | -59.51% | -50.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -271.30% | -261.82% | -243.32% | -53.90% | 2,909.00% |